Comparative Pharmacology
Head-to-head clinical analysis: ACTICORT versus STERI STAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTICORT versus STERI STAT.
ACTICORT vs STERI-STAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production and inflammatory mediators via glucocorticoid receptor binding.
Binds to the 50S ribosomal subunit of bacteria, inhibiting protein synthesis by blocking peptide bond formation and translocation.
5-60 mg orally once daily, or divided twice daily, depending on condition severity and response.
Adults: 1 gram intravenously every 8 hours infused over 60 minutes.
None Documented
None Documented
1.5-2.5 hours; prolonged in hepatic impairment (up to 10 hours) and renal impairment (up to 6 hours)
Terminal elimination half-life is 8-12 hours in adults with normal renal function; prolonged to 18-24 hours in moderate renal impairment (CrCl 30-50 mL/min).
Renal (70% as unchanged drug and metabolites), biliary/fecal (30%)
Renal excretion of unchanged drug accounts for approximately 95% of elimination; biliary/fecal elimination is minimal (<5%).
Category C
Category C
Corticosteroid
Corticosteroid